12
results
for author:"Fournier G."
in Literature Citations
| Association between estrogen and androgen receptor genes and prostate cancer risk. Nicolaiew N., Cancel-Tassin G., Azzouzi A.R., Grand B.L., Mangin P., Cormier L., Fournier G., Giordanella J.P., Pouchard M., Escary J.L. et al. Eur. J. Endocrinol. 160:101-106(2009) · Mapped (67) |
| Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens. Cussenot O., Azzouzi A.R., Nicolaiew N., Fromont G., Mangin P., Cormier L., Fournier G., Valeri A., Larre S., Thibault F. et al. J. Clin. Oncol. 25:3596-3602(2007) · Mapped (26) |
| Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk: an explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors. Cussenot O., Azzouzi A.R., Nicolaiew N., Mangin P., Cormier L., Fournier G., Valeri A., Cancel-Tassin G. Eur. Urol. 52:1082-1087(2007) · Mapped (1) |
| Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer. Letessier A., Garrido-Urbani S., Ginestier C., Fournier G., Esterni B., Monville F., Adelaide J., Geneix J., Xerri L., Dubreuil P. et al. Oncogene 26:298-307(2007) · Mapped (23) |
| FcgammaRIIIb and complement component C7 codeficiency in a patient with recurrence of fulminant meningococcal septic shock. Debard A.L., Lamy B., Monneret G., Mira J.P., Pachot A., Kleijer M., Aillaud M.F., Boibieux A., Bienvenu J., Carret G. et al. Clin. Infect. Dis. 40:1679-1683(2005) · Mapped (9) |
| Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism. Rousseva A., Henry C., van den Bulke D., Fournier G., Laplanche J.L., Leboyer M., Bellivier F., Aubry J.M., Baud P., Boucherie M. et al. Pharmacogenomics J. 3:101-104(2003) · Mapped (4) |
| Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Wei J., Goldberg M.B., Burland V., Venkatesan M.M., Deng W., Fournier G., Mayhew G.F., Plunkett G. III, Rose D.J., Darling A. et al. Infect. Immun. 71:2775-2786(2003) · UniProtKB (3,786) |
| Impact of constitutional genetic variation in androgen/oestrogen-regulating genes on age-related changes in human prostate. Azzouzi A.R., Cochand-Priollet B., Mangin P., Fournier G., Berthon P., Latil A., Cussenot O. Eur. J. Endocrinol. 147:479-484(2002) · Mapped (21) |
| CHC1-L, a candidate gene for prostate carcinogenesis at 13q14.2, is frequently affected by loss of heterozygosity and underexpressed in human prostate cancer. Latil A., Morant P., Fournier G., Mangin P., Berthon P., Cussenot O. Int. J. Cancer 99:689-696(2002) · Mapped (7) |
| Serotonin transporter gene polymorphism and psychiatric disorders in NF1 patients. Bellivier F., Laplanche J.L., Fournier G., Wolkenstein P. Am. J. Med. Genet. 105:758-760(2001) · Mapped (4) |
| Vitamin D receptor polymorphisms as markers in prostate cancer. Correa-Cerro L., Berthon P., Haussler J., Bochum S., Drelon E., Mangin P., Fournier G., Paiss T., Cussenot O., Vogel W. Hum. Genet. 105:281-287(1999) · Mapped (6) |
| (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population. Correa-Cerro L., Wohr G., Haussler J., Berthon P., Drelon E., Mangin P., Fournier G., Cussenot O., Kraus P., Just W. et al. Eur. J. Hum. Genet. 7:357-362(1999) · Mapped (8) |
